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Mycobacterium tuberculosis belongs to a large family of soil bacteria which can
degrade a remarkably broad range of organic compounds and utilize them as
carbon, nitrogen and energy sources. It has been proposed that a variety of
mycobacteria can subsist on alternative carbon sources during latency within
an infected human host, with the help of enzymes such as nitrilotriacetate
monooxygenase (NTA-Mo). NTA-Mo is a member of a class of enzymes which
consist of two components: A and B. While component A has monooxygenase
activity and is responsible for the oxidation of the substrate, component B
consumes cofactor to generate reduced ﬂavin mononucleotide, which is required
for component A activity. NTA-MoB from M. thermoresistibile, a rare but
infectious close relative of M. tuberculosis which can thrive at elevated
temperatures,hasbeen expressed, puriﬁed and crystallized. The 1.6 A ˚ resolution
crystal structure of component B of NTA-Mo presented here is one of the ﬁrst
crystal structures determined from the organism M. thermoresistibile. The NTA-
MoB crystal structure reveals a homodimer with the characteristic split-barrel
motif typical of ﬂavin reductases. Surprisingly, NTA-MoB from M. thermo-
resistibile contains a C-terminal tail that is highly conserved among
mycobacterial orthologs and resides in the active site of the other protomer.
Based on the structure, the C-terminal tail may modulate NTA-MoB activity in
mycobacteria by blocking the binding of ﬂavins and NADH.
1. Introduction
Bacteria within the Mycobacterium genus include M. tuberculosis, the
pathogen responsible for tuberculosis (TB), a disease which has
infected millions worldwide (Anderton et al., 2006; Rylance et al.,
2010). This highly contagious disease is responsible for three million
deaths per year and highly regulated facilities are needed to study it
owing to its ease of transmission. Over 120 species of Mycobacterium
have been identiﬁed to date, many of which can cause disease,
particularly in individuals with suppressed or compromised immunity
(Neonakis et al., 2007). M. thermoresistibile is a non-tuberculous
species of Mycobacterium which has had multiple pathology reports
over the years, including a recent identiﬁcation in an infected patient
(Neonakis et al., 2009). As its name implies, M. thermoresistibile
thrives at elevated temperatures and unlike most other mycobacteria
it can survive in culture at 333 K for up to 4 h (Weitzman et al., 1981;
Tsukamura, 1966). Although relatively rare, increasing evidence of its
ability to infect humans and the fact that it shares many homologous
genes with M. tuberculosis warrants further study of this pathogenic
organism for possible therapeutic intervention (Weitzman et al., 1981;
Kremer et al., 2002; Boloorsaz et al., 2006).
Mycobacteria are named for their ability to produce mycolic acid,
and bacteria from this genus are capable of degrading a wide range of
organic compounds (Savvi et al., 2008). Like other microorganisms,
various mycobacteria can use small organic compounds such as
nitrilotriacetate (NTA) as their sole source of nitrogen, carbon and
energy, allowing rapid adaptation to varying conditions within the
host (Uetz et al., 1992; Bally et al., 1994). Recent reports predicted
that M. tuberculosis could subsist on alternative carbon sources
during persistence within the human host, speciﬁcally during its
macrophage infection period, where by nature it needs to endure
glucose deﬁciency and an abundance of fatty acids. The complexrepertoire of genes involved in lipid metabolism in Mycobacterium is
thus a key factor in its strong pathogenicity (Van der Geize et al.,
2007; Savvi et al., 2008). Nitrilotriacetate monooxygenase (NTA-Mo)
is an oxidoreductase and a member of the family of two-component
monooxygenases which initiates the oxidation of NTAunder aerobic
conditions (van Berkel et al., 2006). This enzyme is comprised of two
parts: component A (NTA-MoA), which has monooxygenase activity
and is responsible for the oxidative conversion of NTA to imino-
diacetate (IDA) and glyoxylate, and component B (NTA-MoB), a
ﬂavin reductase which consumes NADH to reduce FMN to FMNH2,
which is a required cofactor in the oxidization step. The combined
NTA-Mo assembly as whole is categorized as a class C ﬂavoprotein
monooxygenase (van Berkel et al., 2006). The amino-acid alignment
and the three-dimensional structure motif of NTA-MoB from
M. thermoresistibile (MthNTA-MoB) associate it with a family of
short-chain ﬂavin reductases. This group of proteins exists in many
eukaryotic and prokaryotic organisms, including all mycobacteria
(Knobel et al., 1996). Here, we report the 1.6 A ˚ resolution crystal
structure of MthNTA-MoB, a homolog of Rv3567c from M. tuber-
culosis (Mtu) in a highly conserved family within Mycobacterium.A t
the time of writing, it is one of only ﬁve entries for M. thermo-
resistibile available in theProtein Data Bank (PDB), all of whichhave
been solved by the Seattle Structural Genomics Center for Infectious
Disease (SSGCID).
2. Methods
2.1. Protein expression and purification
The gene for the full-length NTA-MoB protein (Target DB
MythA.00250.a; GenBank accession No. HQ644138; NCBI YP_
890259.1; A0R521 homolog) spanning residues 1–189 (‘ORF’) was
ampliﬁed from M. thermoresistibile Tsukamura strain ATCC19527/
NCTC10409 (genomic DNA and sequence information provided by
Dr Christoph Grundner, Seattle Biomedical Research Institute) and
clonedintoapAVA0421vectorencodinganN-terminalhexahistidine-
afﬁnity tag followed by the human rhinovirus 3C protease cleavage
sequence (MAHHHHHHMGTLEAQTQGPGS-ORF; Alexandrov
et al., 2004) by ligation-independent cloning (LIC; Aslanidis &
de Jong, 1990). The plasmid construct for MthNTA-MoB
(MythA.00250.a.A1) was transformed into Escherichia coli BL21
(DE3) Rosetta cells. An overnight culture was grown in LB broth at
310 K and was used to inoculate 2 l ZYP-5052 auto-induction
medium, which was prepared as described by Studier (2005).
MthNTA-MoB protein was expressed in a LEX bioreactor in the
presence of antibiotics. After 24 h at 298 K, the temperature was
reduced to 288 K for a further 60 h. The sample was centrifuged at
4000g for 20 min at 277 K and the cell paste was ﬂash-frozen in liquid
nitrogen and stored at 193 K.
For puriﬁcation, the frozen cell pellet was thawed and completely
resuspended in lysis buffer (20 mM HEPES pH 7.4, 300 mM NaCl,
5% glycerol, 30 mM imidazole, 0.5% CHAPS, 10 mM MgCl2,
3m M  -mercaptoethanol, 1.3 mg ml
 1 protease-inhibitor cocktail,
0.05 mg ml
 1 lysozyme). The resuspended cell pellet was then
disrupted on ice for 15 min with a Branson Digital 450D Soniﬁer
(70% amplitude, with alternating cycles of 5 s pulse-on and 10 s
pulse-off). The cell debris was incubated with 20 ml Benzonase
nuclease at room temperature for 40 min. The lysate was clariﬁed by
centrifugation at 277 K with a Sorvall RC5 at 10 000 rev min
 1 for
60 min. The clariﬁed solution was ﬁltered through a 0.45 mm syringe
ﬁlter (Corning Life Sciences, Lowell, Massachusetts, USA). The
lysate was puriﬁed by IMAC using a HisTrap FF 5 ml column (GE
Biosciences, Piscataway, New Jersey, USA) equilibrated with binding
buffer (25 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 30 mM
imidazole, 1 mM TCEP) and eluted with 500 mM imidazole in the
same buffer. MthNTA-MoB was concentrated without 3C protease
cleavage of the hexahistidine tag. The concentrated pool was further
resolved by size-exclusion chromatography (SEC) using a Superdex
75 26/60 column (GE Biosciences) equilibrated with SEC buffer
(20 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP)
attached to an A ¨ KTA FPLC system (GE Biosciences). Peak fractions
were collected and pooled based on purity-proﬁle assessment by
SDS–PAGE. Concentrated pure protein in SEC buffer was ﬂash-
frozen in liquid nitrogen and stored at 193 K. The ﬁnal concentration
(68.9 mg ml
 1) was determined by UV spectrophotometry at 280 nm
and the ﬁnal purity (>97%) was assayed by SDS–PAGE.
2.2. Crystallization
Crystallization trials were set up according to a rational crystal-
lization approach (Newman et al., 2005) using the JCSG+ and PACT
sparse-matrix screens from Emerald BioSystems and Molecular
Dimensions, respectively. 0.4 ml protein solution (68.9 mg ml
 1) was
with mixed with an equal volume of precipitant and set up against
80 ml reservoir solution in sitting-drop vapor-diffusion format in
96-well Compact Jr plates from Emerald BioSystems at 289 K.
Crystals grew in several conditions within 9 d, but the crystal used for
data collection grew in the presence of 0.2 M magnesium chloride,
0.1 M MES pH 6.0 and 20% PEG 6000 (PACT condition B10).
2.3. Data collection and structure determination
A crystal was harvested, cryoprotected using precipitant solution
supplemented with 20% glycerol and vitriﬁed in liquid nitrogen. A
1.6 A ˚ resolution data set was collected under a stream of liquid
nitrogen on Advanced Light Source (ALS) beamline 5.0.2 as part of
the ALS Collaborative Crystallography program (Table 1). The data
were reduced with HKL-2000 (Otwinowski & Minor, 1997). The
structure (Table 2) was solved by molecular replacement using
Bacillus thermoglucosidasius A7 ﬂavin reductase A2 protein-only
dimer from molecules A and B of PDB entry 1rz0 (van den Heuvel et
al., 2004) as a search model in Phaser (McCoy et al., 2007) from the
CCP4 suite (Winn et al., 2011). The asymmetric unit was comprised
of two independent dimers. The ﬁnal model was obtained after
numerous iterative rounds of reﬁnement in REFMAC (Murshudov et
al., 2011) and manual rebuilding in Coot (Emsley & Cowtan, 2004).
The ﬁnal model contained residues Ala3–Ala181 with no internal
gaps for protomer A and a few additional protein residues for each of
the other three protomers. In addition, the ﬁnal model contained one
glycerol molecule (bound to protomer D) and 548 water molecules.
The structure was assessed and corrected for geometry and ﬁtness
structural communications
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Table 1
Data-collection statistics.
Values in parentheses are for the highest of 20 resolution shells.
Space group P212121
Unit-cell parameters (A ˚ ) a = 48.5, b = 91.0, c = 165.6
Wavelength (A ˚ ) 1.000
Resolution range (A ˚ ) 50–1.6 (1.64–1.60)
No. of unique reﬂections 97350 (7102)
Multiplicity 8.2 (7.8)
Completeness (%) 99.8 (99.9)
Rmerge† 0.095 (0.428)
Mean I/ (I) 13.4 (5.4)
† Rmerge =
P
h
P
i jIiðhÞ h IðhÞij=
P
h
P
i IiðhÞ.using MolProbity (Chen et al., 2010). Data-collection results and
structure-reﬁnement statistics are listed in Tables 1 and 2.
3. Results
3.1. Identification of MthNTA-MoB
Rv3567c (UniProt accession No. P96849) is a member of a large
group of genes that are under the control of a ketosteroid regulon,
kstR, which is a member of the tetracycline resistant-like family of
transcriptional regulators (Kendall et al., 2007). Rv3567c is predicted
to be involved in lipid catabolism; this gene has been shown to be
inducible both in palmitic acid and when grown on cholesterol in
Rhodococcus. sp strain RHA1, a soil bacterium related to M. tuber-
culosis (Van der Geize et al., 2007). Rv3567c clusters with about 28
genes speciﬁcally expressed in M. tuberculosis, among which Rv3569c
(hsaD) has been shown to be essential for survival in primary murine
macrophages by a transposon-site hybridization (TraSH) experiment
in M. tuberculosis H37Rv. For these reasons, Rv3567c and related
genes have been assigned to the cholesterol-degradation pathway
(Van der Geize et al., 2007; Rengarajan et al., 2005). Although NTA-
MoB tends to be highly conserved across Mycobacterium species,
only one homolog was found in the UniProt database at the outset of
this work: that from M.smegmatis (A0R521). A search for NTA-MoB
homologs in M. tuberculosis in the TubercuList database (http://
genolist.pasteur.fr/TubercuList/) resulted in a match to Rv3567c
(Cole et al., 1998). The MthNTA-MoB protein consists of 189 amino-
acid residues and is 82% identical (89% similar) to MtuNTA-MoB,
which in turn matches 100% to Rv3567c in TubercuList. In addition,
MthNTA-MoB is at least 80% identical to all other known Myco-
bacterium orthologs, including that from M. smegmatis (A0R521).
During target selection, 21 additional paralogs of NTA-MoB were
selected and have entered the SSGCID pipeline, including those from
M. abscessus, M. avium, M. bovis, M. leprae, M. marinum, M. para-
tuberculosis, M. smegmatis and M. ulcerans. Among these 21 homo-
structural communications
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Figure 1
Protein sequence alignment of MthNTA-MoB (PDB entry 3nfw) with other short-chain ﬂavin reductases. The secondary-structural elements of 3nfw are indicated and
labelled above the aligned sequences. The similarity levels for each of the amino-acid positions are indicated using a grayscale, where darker shades indicate a higher degree
of conservation. Strictly conserved residues are shown in black, while lighter grays and white indicate various degrees of low conservation and no conservation, respectively.
Conserved residues shared with other short-chain ﬂavin reductases are marked with an asterisk at the bottom of the column. Color legend for sequence identity: green,
conserved; yellow, similar; red, unconserved. Details of the proteins aligned with 3nfw are shown in Table 3.
Table 2
Reﬁnement and model statistics.
Values in parentheses are for the highest of 20 resolution shells.
Resolution range (A ˚ ) 20–1.6 (1.64–1.60)
Rcryst† 0.186 (0.180)
Rfree† 0.217 (0.227)
R.m.s.d. bonds (A ˚ ) 0.015
R.m.s.d. angles ( ) 1.273
Protein atoms 6109
Heteroatoms 6
Waters 548
Mean B factor (A ˚ 2) 16.7
Residues in favored region (%) 97.6
Residues in allowed region (%) 100
MolProbity‡ score [percentile] 0.91 [100th]
† Rcryst =
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj. The free R factor was calculated with the 5%
of the reﬂections that were omitted from the reﬁnement (Winn et al., 2011). ‡ Chen et
al. (2010), Davis et al. (2007).logs, 12 were successfully cloned, expressed and puriﬁed and three
formed crystals, one of which (MthNTA-MoB) diffracted to sufﬁ-
ciently high resolution for structure determination.
3.2. Comparison with other short-chain flavin reductases
A search of the Protein Data Bank (http://www.rcsb.org/pdb/)
resulted in no proteins with a sequence similarity greater than 35% to
MthNTA-MoB.ThePfamdatabase(http://www.sanger.ac.uk/software/
pfam) assigned MthNTA-MoB to the PF01613 family of proteins with
the FMN-binding split-barrel motif at an E value of 8.7   10
 40.T h i s
NADH:FMN oxidoreductase or ﬂavin reductase family was ﬁrst
described in the early 1990s and exists in many organisms, primarily
Gram-negative bacteria (Uetz et al., 1992; Blanc et al., 1995). These
short-chain ﬂavin reductases are involved in a variety of biological
reactions and often act in concert with a ﬂavin-dependent mono-
oxygenase which oxidizes through the addition of molecular oxygen
(Kirchner et al., 2003; Gala ´n et al., 2000). However, they do not share
sequence homology with ﬂavin reductases found in E. coli or lumi-
nous bacteria or with the LuxG protein class found in lux operons
(Nijvipakul et al., 2008).
A sequence alignment of MthNTA-MoB with other members of
the short-chain ﬂavin reductase family is shown in Fig. 1. Sequences
were selected either based on structural homology or owing to well
reported functional similarity (Valton et al., 2008; Filisetti et al., 2003).
MthNTA-MoB shares many conserved residues within this family of
short-chain ﬂavin reductases, including Arg12, Gly35, Pro48, Leu76,
Phe88, His130 and Leu152 (Fig. 1). However, the overall sequence
similarity is low, despite high E values in structural classiﬁcation.
Table 3 lists the amino-acid identities and structural similarities of
MthNTA-MoB to a variety of other enzymes involved in the degra-
dation of small organic compounds based on search results using
DALI (Holm & Sander, 1993). In particular, the MthNTA-MoB
structure bears marked homology to the phenol 2-hydroxylase
component B of reduced ﬂavin reductase from B. thermo-
glucosidasius (BtPheA2;PDB entry 1rz1; van denHeuvel etal., 2004).
3.3. Three-dimensional structure of MthNTA-MoB
The native MthNTA-MoB protein crystallized in the orthorhombic
space group P212121 and an apo structure was determined to a
resolution limitof 1.6 A ˚ (PDB entry 3nfw) with Rcryst and Rfree factors
of 0.186 and 0.217, respectively (Table 2). MthNTA-MoB consists of
11  -strands and ﬁve  -helices, with seven antiparallel  -sheet core
regions forming a split-barrel motif capped by an  -helix (Fig. 2).
Consistent with observations from size-exclusion chromatography,
the biological molecule observed within the crystal lattice is a dimer
and the crystal structure contained two noncrystallographically
related dimers. PISA (Krissinel & Henrick, 2007) calculated a total
buried surface area of 8610 A ˚ 2 and a change in solvent free energy of
 234 kJ mol
 1 upon dimerization.
The spatial difference between C
  atoms of MthNTA-MoB and
BtPheA2 is 0.98 A ˚ , indicating a high degree of structural conserva-
tion for two proteins with only 32% sequence similarity (Fig. 3).
Unlike the MthNTA-MoB structure, crystal data for BtPheA2 were
acquired with the cofactor NADPH bound. According to structure-
alignment results generated using the SSM (PDBe) server (http://
www.ebi.ac.uk/msd-srv/ssm/cgi-bin/ssmserver), the loop region at
amino-acid residues Gly88–Asp99 (between  -helix 3 and  -strand 6)
has the lowest level of amino-acid residue alignment. This loop forms
a critical part of the binding pocket recognized by FMN, with the
analogous loop reported to be involved in binding either FAD or
FMN in PheA2 and ferric reductase, respectively (van den Heuvel et
al., 2004; Okai et al., 2006). This loop has been described as ﬂexible in
the absence of FMN but highly ordered in FMN-bound structures. In
the MthNTA-MoB structure the loop region has the highest deviation
from the structure of substrate-bound BtPheA2. While the average
distance between superimposed pairs of residues ranges from 1.29 to
4.42 A ˚ , with the greatest deviation at Ala96, the overall C
  r.m.s.d. is
only 0.98 A ˚ (Fig. 3a).
The other region in which MthNTA-MoB deviates most from the
BtPheA2 structure is in the C-terminal loop region from Lys165 to
Thr182 (Fig. 3b). This region adopts the same conformation in all four
protomers in the asymmetric unit and is ﬂexible and adjacent to the
NADH-binding cleft (Deng et al., 1999). It is expected to play an
inhibitory role in substrate (ﬂavin) and cofactor (NADH) binding
(van den Heuvel et al., 2004). However, further structural data are
necessary to conﬁrm the interaction of the loop with cofactor bound
to the same molecule or a neighboring molecule.
4. Discussion
The reaction mechanism of this class of enzymes has been a topic of
discussion in recent years (Filisetti et al., 2003; van den Heuvel et al.,
2004; Valton et al., 2008). One group proposed the ping-pong
mechanism, while others described the reactions as following an
ordered sequential mechanism. The ﬂexible C-terminal region in the
3nfw structure could potentially play a role in inhibiting cofactor
binding and/or release. However, without further evidence of a
bound substrate or cofactor and a lack of functional analysis it is
difﬁcult to support either of the mechanisms one way or the nother.
Previous publications have suggested that lipid metabolism is
fundamental to the unusual ability of M. tuberculosis to use fatty
acids as a sole carbon source and survive in vivo (Van der Geize et al.,
2007). Recent reports further predict that M. tuberculosis subsists on
structural communications
Acta Cryst. (2011). F67, 1100–1105 Zhang et al.   Nitrilotriacetate monooxygenase component B 1103
Table 3
Amino-acid identity and structural similarity across the top eight structural homologs of 3nfw available in the PDB.
Data based on the RCSB PDB (http://www.pdb.org/pdb/).
PDB
code
UniProt
ID Protein name Organism
Amino-acid
identity (%)
R.m.s.d.
(A ˚ ) Reference
2rox Q0I3S1 Putative ﬂavin reductase Haemophilus somnus 129PT 21.5 1.27 —
1rz1 Q9LAG2 Phenol 2-hydroxylase component B Bacillus thermoglucosidasius A7 31 1.62 van den Heuvel et al. (2004)
2d37 Q974C9 Phenol 2-hydroxylase component B Sulfolobus tokodaii strain 7 26 1.65 Okai et al. (2006)
2ecu Q5SJP7 Flavin reductase (HpaC) of 4-hydroxyphenylacetate
3-monooxygenase polypeptide (L)
Thermus thermophilus HB8 27 1.73 Kim et al. (2008)
3cb0 Q8YHT7 4-Hydroxyphenylacetate 3-monooxygenase Brucella melitensis 25.2 1.83 Lawrence et al. (2008)
1usc P83818 Styrene monooxygenase small component Thermus thermophilus 20 1.87 —
3k86 087008 Chlorophenol-4-monooxygenase component 2 Burkholderia cepacia 26 2.05 Webb et al. (2010)
2qck A0JVA7 Flavin reductase domain protein Arthrobacter sp. FB24 26 2.13 —
n/a Q02058 Actinorhodin polyketide dimerase Streptomyces coelicolor A3 32 n/a Filisetti et al. (2003), Valton et al. (2008)alternative carbon sources in the human host. Speciﬁcally, M. tuber-
culosis is able to persist in the glucose-deﬁcient and fatty-acid-rich
environment found in the macrophage stage of infection, thereby
contributing to its unparalleled virulence (Savvi et al., 2008). The
up-regulation of the Rv3567c group of enzymes during survival in
macrophages indicated their involvement in cholesterol uptake,
which links them to phagocytosis, a vital step in bacterial pathogenic
metabolism (Van der Geize et al., 2007). An important role in
cholesterol metabolism and cell survival could be the reason for
the high conservation of these genes. Uncertainties remained in a
previous discussion of the natural substrates of NTA-Mo (Uetz et al.,
1992). It is possible that the structure of the synthetic NTA and its
subsequent degradation products resemble some of the key meta-
bolites in metabolism pathways such as the tricarboxylic acid (TCA)
pathway, hence the analogous activity. Further experiments to
compare the binding afﬁnities of these compounds and their reaction
mechanism may help to answer some of these questions.
5. Conclusion
MthNTA-MoB is 82% identical (89% similar) to MtuNTA-MoB,
which matches 100% to Rv3567c in TubercuList. Rv3567c and related
cluster of genes, some of which are essential, have been assigned to
the cholesterol-degradation pathway in M. tuberculosis. We have
reported the 1.6 A ˚ resolution structure of MthNTA-MoB, one of the
ﬁrst protein structures to be reported for this organism. Structure
structural communications
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Figure 3
C
  trace of molecular superposition of 3nfw (green) and 1rz1 (gray). FAD and
NADH molecules are shown bound to 1rz1. (a) Molecular overlay of the
monomers, with the Gly88–Asp99 loop region and the C-terminal loop region
indicated. (b) Molecular overlay of the dimers, with the Gly88–Asp99 loop region
and the C-terminal loop region of the opposite chain and the FAD and NADH
molecules bound to 1rz1 indicated.
Figure 2
Structural diagrams of 3nfw. (a) Secondary-structural topology diagram. Red
cylinders indicate  -helices and pink arrows represent  -sheets. The beginning and
ending amino-acid residue numbers are indicated inside each of the cylinders or
arrows, together with the sequential numbers of each secondary-structural
component. (b) Ribbon diagram of 3nfw. Pink spirals indicate  -helices and red
arrows represent  -sheets. Secondary-structural elements and N- and C-terminal
residues are indicated.comparisons characterize it as a member of the short-chain ﬂavin
reductase family with a high conﬁdence level. The overall structure
and conserved amino-acid residues align well with those of other
proteins, despite low sequence homology. Two of the loop regions
showed deviations in a structural overlay with other members of the
family, including those in which the cofactor is bound. The density
was sufﬁcient to allow modelling of the long loop at the C-terminus, a
region that is often absent in structures obtained using crystallo-
graphic data owing to a high degree of ﬂexibility, and may provide
additional insight into its role in modulating activity via access for
cofactor binding.
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